Results 121 to 130 of about 8,578 (238)

Design and In Vivo Characterization of Immunoconjugates Targeting HIV gp160

Journal of Virology, 2016
S. Pincus, K. Song, G. Maresh, A. Frank, D. Worthylake, H. Chung, P. Polacino, D. Hamer, C. Coyne, M. Rosenblum, J. W. Marks, Gang Chen, D. Weiss, V. Ghetie, E. Vitetta, James E. Robinson, Shiu-Lok Hu   +16 more
semanticscholar   +1 more source

Theranostic vNAR-Based Immunoconjugates Achieve Selective Intracellular Cisplatin Delivery in Embedded 3D HER2-Positive Breast Cancer In Vitro Model. [PDF]

Pharmaceuticals (Basel)
Alfonseca-Ladrón de Guevara AC, Manzanares-Guzmán A, Badillo-Mata JA, Burciaga-Flores M, Lugo-Fabres PH, Camacho-Villegas TA.   +5 more
europepmc   +1 more source

Comparative In Vitro Evaluation of Anti-HIV Immunotoxin, Antibody-Drug Conjugate, and Radioimmunoconjugate Targeted by the Same Antibody. [PDF]

Antibodies (Basel)
Kuhlmann AS, Peters T, Hamlin DK, Li Y, Wang X, Stackhouse M, Cole FM, Martinez-Reyes J, Sandmaier BM, Kiem HP, Wilbur DS, Harrington RD, Pincus SH.   +12 more
europepmc   +1 more source

Preclinical characterization of 3p-C-DEPA_-NCS and 3p-C-DEPA_-TFP-PEG₄ as potential Actinium-225 bifunctional chelators using DOTA_-NCS and macropa_-NCS as benchmarks. [PDF]

EJNMMI Radiopharm Chem
Pougoue Ketchemen J, Ahenkorah S, Nwangele E, Malaza SSP, Ooms M, Cardinaels T, Leekens S, Cleeren F, Fonge H.   +8 more
europepmc   +1 more source

Site-specifically labeled CA19.9-targeted immunoconjugates for the PET, NIRF, and multimodal PET/NIRF imaging of pancreatic cancer

Proceedings of the National Academy of Sciences of the United States of America, 2015
J. Houghton, Brian M. Zeglis, Dalya Abdel-Atti, R. Aggeler, Ritsuko Sawada, B. Agnew, W. Scholz, Jason S. Lewis   +7 more
semanticscholar   +1 more source

Development of Optimized Exatecan-Based Immunoconjugates with Potent Antitumor Efficacy in HER2-Positive Breast Cancer. [PDF]

J Med Chem
Auvert E, Douez E, Jolivet L, Witkowski T, Jallas AC, Boursin F, Molnar I, Colas C, Wittmann SV, Auriol M, Chezal JM, Aubrey N, Allard-Vannier E, Maisonial-Besset A, Joubert N, Denevault-Sabourin C.   +15 more
europepmc   +1 more source

The Next Wave of Immunotherapy: A Critical Review of Nanotechnology Strategies for Immune Checkpoint Blockade. [PDF]

Pharmaceutics
Almuqbil RM.
europepmc   +1 more source

Precision Labeling of Native Antibodies with Lock Coupling. [PDF]

J Am Chem Soc
Liu Y, Nadig I, Mehta AS, Chuo SW, Ho YH, Tyler J, Craik CS, Anwar M, Cohen BE.   +8 more
europepmc   +1 more source

Photodynamic targeting with photosensitizer immunoconjugates.

, 2000
Photosensitizer immunoconjugates (PICs) offer improved photosensitizer delivery specificity and could broaden the applicability of photodynamic therapy (PDT) in the treatment of various lesions (e.g., tumors, bacterial infections, atherosclerotic lesions)
Savellano, Mark David
core  

Harnessing Fc-Directed Bioconjugation for the Synthesis of Site-Specifically Modified Radioimmunoconjugates. [PDF]

Bioconjug Chem
Grimaldi C, Sebastiano J, Kao WM, Strugala E, McGlone SA, Watanabe T, Aoki T, Fujii T, Zeglis BM.   +8 more
europepmc   +1 more source